The First Clinical Medical College of Lanzhou University, No. 222 Tianshui South Road, Lanzhou, Gansu Province, 730000, China.
Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region, Urumqi, 830039, China.
BMC Cancer. 2024 Oct 7;24(1):1233. doi: 10.1186/s12885-024-13003-0.
A Two-sample Mendelian randomization (MR) Analysis was used to assess the causal relationship between non-small cell lung cancer (NSCLC) and sepsis.
Single nucleotide polymorphisms (SNPs) closely associated with NSCLC were utilized as instrumental variables (IVs) in this study. The Inverse Variance Weighted (IVW) method was used as the primary method for MR analysis, supplemented by the Weighted median, Weighted model, and MR-Egger regression method. Sensitivity analysis was conducted to improve result robustness, and data from various sources were validated and integrated. Bonferroni tests were applied to adjust for multiple comparisons.
After Bonferroni tests correcting the combined results, MR analysis revealed a significant association between genetically predicted NSCLC and an increased susceptibility to sepsis (odds ratios [OR]: 1.140, 95% confidence interval [CI]: 1.085-1.199, P = 2.61 × 10). The combined results demonstrated that NSCLC is associated with a heightened risk of sepsis in patients under 75 years of age (OR: 1.085, 95%CI: 1.037-1.353, P = 3.84 × 10). Furthermore, lung adenocarcinoma (LUAD) was found to be potentially associated with an increased susceptibility to sepsis (OR: 1.040, 95% CI: 1.009-1.073, P = 1.16 × 10). These results withstood multiple sensitivity analyses, demonstrating their robustness.
This study confirms that NSCLC can significantly increase susceptibility to sepsis at the genetic level, providing valuable insights for the early identification of individuals at risk for sepsis.
采用两样本孟德尔随机化(MR)分析来评估非小细胞肺癌(NSCLC)与脓毒症之间的因果关系。
本研究使用与 NSCLC 密切相关的单核苷酸多态性(SNP)作为工具变量(IV)。采用逆方差加权(IVW)法作为 MR 分析的主要方法,同时辅以加权中位数、加权模型和 MR-Egger 回归法。进行敏感性分析以提高结果稳健性,并验证和整合来自不同来源的数据。应用 Bonferroni 检验校正多重比较。
经 Bonferroni 检验校正合并结果后,MR 分析显示,遗传预测的 NSCLC 与脓毒症易感性增加之间存在显著关联(比值比 [OR]:1.140,95%置信区间 [CI]:1.085-1.199,P=2.61×10)。合并结果表明,对于 75 岁以下的患者,NSCLC 与脓毒症风险升高相关(OR:1.085,95%CI:1.037-1.353,P=3.84×10)。此外,肺腺癌(LUAD)可能与脓毒症易感性增加相关(OR:1.040,95%CI:1.009-1.073,P=1.16×10)。这些结果经过多次敏感性分析验证,具有稳健性。
本研究证实 NSCLC 可在遗传水平上显著增加对脓毒症的易感性,为早期识别脓毒症高危人群提供了有价值的信息。